Imatinib was developed by Novartis. It was first approved by the US Food and Drug Administration (FDA) on May 10, 2001, and then by the European Medicines Agency (EMA) on November 7, 2001. On March 9, it was authorized to be placed on the market. by the Japan Pharmaceuticals and Medical Devices Agency (PMDA). It is marketed in the United States by Novartis under the brand name Gleevec. Imatinib is a Bcr-Abl tyrosine kinase inhibitor that inhibits the proliferation and apoptosis of Bcr-Abl positive cell lines and fresh cells of Philadelphia chromosome-positive chronic myelogenous leukemia. Indian generic Veenat 400mg , Veenat 100mg is available with the same active ingredient imatinib. The price of imatinib is not cheaper if you choose a brand name.
How should Imatinib be taken?
This medication should be taken with a meal and a large glass of water to minimize the risk of gastrointestinal upset. For patients who cannot swallow tablets, dissolve the tablets in still water or apple juice (about 50 ml for 100 mg, 200 ml for 400 mg), mix the suspension and take as soon as tablet completely disintegrated.
Side effects
The safety profile of Imatinib has been extensively studied.
Most patients experience some side effect when using the drug. The most common side effects (>10%) were: neutropenia, thrombocytopenia, anemia, headache, dyspepsia, edema, weight gain, nausea, vomiting, diarrhea, myalgia, muscle spasms, rash, weakness, stomach pain.
These side effects were generally mild to moderate in severity. Only 2-5% of patients discontinued Imatinib treatment due to adverse events.
Myelosuppression, gastrointestinal adverse events, edema, and rash occur with imatinib in both CML and malignant gastrointestinal stromal tumors.
Patients with CML are more likely to develop myelosuppression, while patients with malignant stromal tumors of the gastrointestinal tract are more likely to experience gastrointestinal and intratumoral bleeding.
Other gastrointestinal abnormalities, such as gastrointestinal obstruction, perforation, and ulceration, are more common in gastrointestinal stromal tumors.
Consult your doctor for more information. Let's look at the price of Imatinib below .
Imatinib price and availability
The price of Imatnib is the lowest here. It costs only 4% of the Gleevec brand. If you are looking for Imatinib price in the Philippines, USA, you are in the right place. Medixo Center offers easy and best access to Imatinib, a highly effective drug for the treatment of leukemia. With a very easy purchase and fast delivery, you can get the medicine you want without any problems. You can buy Imatinib online from us at the best price with worldwide shipping. Contact us for price information.
You can send your inquiry here.
Call/WhatsApp/Viber/Telegram/Signal: +91-9999344593
www.medixocentre.com
Email: info@medixocentre.com
